Paper Review Records
All Paper Review Records
15 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
129
days
En-bloc vs lobe-by-lobe laser prostatectomy: where do we stand?
Authors
Mahmoud Laymon; Yahya H. Elmorsy; Ahmed M. Elshal; Ahmed R. El-Nahas; Ahmed M. El-AssmyShow moreShow less
Affiliations
1. Urology and Nephrology Center, Mansoura University, Mansoura, EgyptShow moreShow less
59
days
Methodological and clinical considerations of MRI-based prostate cancer risk calculators
Authors
Werner T. W. de Riese; Aaron De Souza; Chase RenstromShow moreShow less
Affiliations
1. Department of Urology, Texas Tech University Health Sciences Center, Lubbock, USAShow moreShow less
190
days
Efficacy and safety of darolutamide plus androgen-deprivation therapy in Black patients with metastatic hormone-sensitive prostate cancer from the phase 3 ARANOTE trial
Authors
Quoc-Dien Trinh; Daniel J. George; Neal Shore; Egils Vjaters; David Olmos; Andrea Juliana P. de Santana Gomes; Augusto Cesar de Andrade Mota; Natasha Littleton; Shankar Srinivasan; Frank Verholen; Kunhi Parambath Haresh; Fred SaadShow moreShow less
Affiliations
1. University of Pittsburgh Medical Center, Pittsburgh, USA; 2. Duke University School of Medicine, Duke Cancer Institute, Durham, USA; 3. Carolina Urologic Research Center and AUC Urology Specialists, Myrtle Beach, USA; 4. P. Stradinš Clinical University Hospital, Riga, Latvia; 5. Department of Medical Oncology, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre (Imas12), Madrid, Spain; 6. Liga Norte Riograndense Contra O Cancer, Natal, Brazil; 7. Medical Oncology, Instituto ETICA – Clinica AMO/DASA, Salvador, Brazil; 8. Bayer Ltd, Dublin, Ireland; 9. Bayer Healthcare, Whippany, USA; 10. Bayer Consumer Care AG, Basel, Switzerland; 11. All India Institute of Medical Sciences, New Delhi, India; 12. University of Montreal Hospital Centre, Montreal, CanadaShow moreShow less
72
days
Missing the full picture: Pathology, anatomy, and operator effects in HoLEP comparisons
Authors
Zuomin Wang; Qinwei Liu; Wangdong DengShow moreShow less
Affiliations
1. Urology of Shenzhen Longgang Central Hospital, Shenzhen, ChinaShow moreShow less
129
days
Letter: The Hawthorne effect—behavioral changes from research observation—as confounder and mediator in the ERASE trial
Authors
Zuomin Wang; Qinwei Liu; Wangdong DengShow moreShow less
Affiliations
1. Urology of Shenzhen Longgang Central Hospital, Shenzhen, ChinaShow moreShow less
127
days
Navigating drug–drug interactions with apalutamide
Authors
Bilal A. Siddiqui; Karine Tawagi; Sarah Caulfield; Pankaj Aggarwal; Tanya DorffShow moreShow less
Affiliations
1. Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA; 2. Department of Medicine, Division of Hematology and Oncology, University of Illinois Chicago, Chicago, USA; 3. Genitourinary Clinic, Emory Healthcare, Winship Cancer Institute, Atlanta, USA; 4. Johnson & Johnson, Horsham, USA; 5. Department of Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, USAShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
